PMBS News Alert Puramed Bioscience (PMBS) 0.0001 02/15/2015
Post# of 64074
PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H
PR Newswire - Tue Dec 23, 7:00AM CST
PuraMed BioScience®, Inc., (OTC Pink: PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced it received the initial funding to begin final production of MigraPure® H, a hemp-based, advanced headache relief product, for planned distribution to 1,000 medical and recreational marijuana dispensaries in Colorado, Washington State, and California.
PuraMed BioScience Completes Distribution Agreement with FastFunds Financial Corporation for Its Migraine Relief Product
PR Newswire - Tue Dec 09, 7:00AM CST
PuraMed BioScience®, Inc., (OTC Pink: PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that it has entered into a 5-year distribution agreement with FastFunds Financial Corporation (OTC Pink: FFFC) of West Palm Beach, Florida for distribution of MigraPure® H, a hemp-based, advanced migraine relief product.
PuraMed BioScience Completes the First Production of MigraPure® Gel
PR Newswire - Wed Aug 13, 11:28AM CDT
PuraMed BioScience®, Inc., (OTCPink MBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that the company has completed its first batch of its patented, sublingual MigraPure® gel containing feverfew and ginger with an enhanced flavor.
PuraMed BioScience to add Cannabis-based epilepsy medication to its product line
M2 - Wed Aug 06, 5:53AM CDT
OTC medicinal company PuraMed BioScience (Other OTC MBS) said on Tuesday that it intends to begin testing a new hemp-based epilepsy medication in the fourth quarter of 2014.
PuraMed BioScience Develops a Cannabis-based Epilepsy Medication
PR Newswire - Tue Aug 05, 1:00PM CDT
PuraMed BioScience®, Inc., (OTCPink: PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that it plans to begin testing of a new hemp-based epilepsy medication in the fourth quarter of 2014.
PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M
PR Newswire - Wed Jul 30, 12:57PM CDT
PuraMed BioScience®, Inc., (OTCPink MBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that the company is rebranding the LipiGesic® M name along with the name's red and yellow logo. The former will be replaced with the trademarked name MigraPure® going forward. The new name, logo, and color palette of PuraMed's homeopathic, natural migraine pain reliever will be reintroduced into selected segments of the retail marketplace.
PuraMed BioScience forms corporate sponsor partnership with Operation Troop Aid for US military
M2 - Wed Jul 23, 7:38AM CDT
Healthcare company PuraMed BioScience (PNK MBS) reported on Tuesday the launch of a corporate sponsor agreement with Operation Troop Aid in aid of the US military.
PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages
PR Newswire - Tue Jul 22, 7:49AM CDT
PuraMed BioScience®, Inc., (OTCBB: PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that the company is a corporate sponsor of Operation Troop Aid.
PuraMed BioScience Announces Product Donation at a Sponsorship Level to Operation Gratitude
PR Newswire - Tue Jul 08, 8:11AM CDT
PuraMed BioScience®, Inc., (OTCBB MBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that the company is now a corporate sponsor of Operation Gratitude.
Energy Utilities Focus on Providing Reliable and Safe Service while Meeting Compliance Standards
PR Newswire - Wed Feb 26, 7:00AM CST
To streamline and standardize gas compliance processes and adapt to the demands of the energy service and delivery industry, Ameren Corporation has turned to the mobile workforce management market leader, ClickSoftware Technologies Ltd. (NasdaqGS: CKSW). The implementation of ClickSoftware's scheduling and mobility offering for gas compliance processes will eliminate paper inspection forms and improve data quality, improve flexibility to adapt to rapidly changing regulatory requirements, and provide management with greater visibility into compliance activities.
CKSW: 8.08 (-0.01), AEE: 41.54 (-1.12)